BAP1 at 3p21.1 is involved in BRCA1-related tumor growth suppression, and germline mutations in patients with BAP1 tumor predisposition syndrome have been reported to be associated with familial RCC [23,24]. Here, BAP1 is linked to renal cell carcinoma.